Puma Biotechnology Inc expected to post a loss of 5 cents a share - Earnings Preview

Puma Biotechnology

02/11/2022 02:13

* Puma Biotechnology Inc  PBYI.OQ   PBYI.O  is expected
to show a
rise in quarterly revenue when it reports  results on November
3. 
    * The Los Angeles California-based  company is expected to
report 
a 9.2% increase in revenue to $50.467 million from $46.2 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Puma Biotechnology
Inc is
for a loss of 5 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and 2 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Puma
Biotechnology Inc is $5​, above​ its last closing price
of $2.25. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  0.01        0.01       0.21      Beat    1,958.
                                                        8
 Mar. 31 2022  -0.16       -0.17      -0.08     Beat    51.8
 Dec. 31 2021  -0.08       -0.09      0.10      Beat    214.2​
 Sep. 30 2021  -0.32       -0.31      -0.90     Missed  -188.8
 ​​Jun.        -0.25       -0.27      -0.13     Beat    52.1
 30 2021                                                
 Mar. 31 2021  0.16        0.09       0.40      Beat    359.8​
 Dec. 31 2020  -0.41       -0.31      -0.38     Missed  -21.7
 Sep. 30 2020  -0.41       -0.39      -0.79     Missed  -100.1
 This summary was machine generated November 2 at 02:12 GMT.  All
figures in US dollars  unless otherwise stated